Good capitalists can agree that those who develop cutting-edge drugs deserve to be richly rewarded for their efforts. But then Americans must ask why they alone must bear the costs of bestowing the rewards.
Calling Valeant a “drug company” is problematic because it’s not much into researching and developing new medications. “Bet on management, not on science,” its outgoing CEO, J. Michael Pearson, was fond of saying.
Shkreli, 32, sparked outrage last year after his company raised the price of 62-year-old drug Daraprim by more than 5,000 percent, to $750 a pill.
Larry Wilmore celebrates the arrest of drug CEO for alleged Ponzi scheme: “Some people just need to die — and it shouldn’t be the AIDS and cancer patients.”
Man who caused public outrage after raising price of a prescription drug by more than 5,000 percent, was arrested Thursday for alleged Ponzi-like scheme.
Martin Shkreli has also done the American people a service by showing in high def how the pharmaceutical industry gouges us on a regular basis.
Stephen Colbert was excited for Pope Francis’ visit to New York, so much so that he invited the leader of the Catholic Church to appear on his show.